ABOUT

ARNICA MONTANA

Arnica montana extract contains, amongst other components, Helenaline which is a sesquiterpene lactone with potent anti-inflammatory effects. The other components of the extract provide antimicrobial, venotonic and blood vessel protective effect.

 

Arnica is currently found in liniment and ointment preparations used for alleviating the symptoms of muscle and ligamentous strains, sprains and bruises. Commercial Arnica preparations are frequently prescribed by medical professionals to assist in the treatment of these conditions.

HORSE CHESTNUT

The main active ingredient in Horse chestnut is Escin. Escin has anti-inflammatory and venotonic properties, which decrease blood-vessels’ permeability and produce an important anti-edema effect. Flavonoids, another active ingredient, have a wide range of actions: remarkably, reduction of capillary fragility and permeability, anti-inflammatory action
and free radical scavenging action. Due to the effect of Horse chestnut
on the function of the capillaries, oxygen and nutrient transport to the cells and the removal of excess water and waste products from the cells, will
be enhanced. This has benefit for muscle healing and repair and
venous support.

WHAT IS MYO₂
THERAPEUTIC GEL?

 

MYO₂ was developed in 2010 as a therapeutic gel for relieving the symptoms of soft tissue and joint injury. MYO₂ contains two essential, natural active ingredients, namely Arnica montana and Horse chestnut.

 

Soft tissue includes muscles, nerves, tendons, ligaments, fascia (a type of connective tissue), blood vessels, fat and skin. This tissue either connects, supports or surrounds structures and organs of the body.

 

A joint is the point where two or more bones meet and allow for movement (except your skull) and mechanical support.

 

Inflammation is the complex biological response of joints or soft tissue to being injured. Inflammation results in redness, swelling, pain, heat, tenderness and disturbed function of the part of the body
that was injured.

Hover on dots to see how MYO2 can provide effective relief for a broad spectrum of ailments

RESEARCH

 

Exciting new research due to be published soon by Jonathan Mudditt looks at “Spinal Manipulative Therapy and MYO2 for the Treatment of Posterior Mechanical Neck Pain.” https://ujdigispace.uj.ac.za/bitstream/handle/10210/8317/Muditt.pdf?sequence=1

 

The research involves “the effectiveness of massage with MYO2 gel in conjunction with Spinal Manipulative Therapy (SMT) for the treatment of patients with posterior mechanical neck pain, with regards to pain, disability and cervical spine range of motion.”

 

“The control group received SMT to the cervical spine, followed by massage with inert ultrasound gel over the upper trapezius muscle and the area of the posterior neck musculature. The experimental group received SMT of the cervical spine followed by massage with MYO2 gel over the upper trapezius muscle and the area of the posterior neck musculature.”

 

“Both interventions were effective in decreasing neck pain. The experimental group achieved a greater average Cervical Range of Motion (CROM) percentage increase of 28.60% average compared to the control group with an average percentage increase of 22.25%. There was consistently a greater rate and degree of improvement in the experimental group both overall and initially in comparison to the control group. This difference was seen in terms of statistical significance with a strong indication as to clinical significance.”

 

“On the basis of this research trial, the use of SMT and soft tissue massage with MYO2 is strongly recommended for the treatment of posterior neck pain.”

 

MYO2 sponsors its therapeutic gel at both Chiropractic Clinics at the University of Johannesburg and DUT in Durban.

AVAILABLE AT

© COPYRIGHT RESERVED  |  SPRINTMED MYO2  2014  |  SITE DESIGNED & DEVELOPED BY MORRISON & MORRISON